Publicacions en què col·labora amb Alejandra Ivars Rubio (4)

2024

  1. Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes

    Breast Cancer Research and Treatment, Vol. 205, Núm. 3, pp. 475-485

2023

  1. A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients

    Frontiers in Oncology, Vol. 13

  2. Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer

    Cancers, Vol. 15, Núm. 10

2019

  1. Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables

    Scientific Reports, Vol. 9, Núm. 1